Abstracts from ASENT 2004 Annual Meeting March 11–13, 2004

被引：0

作者：

Yuyan Duan

Ilya Lipkovich

Saeeduddin Ahmed

Jonna Ahl

Thomas Hardy

Diane Haldane

Robert Baker

Mauricio Tohen

Hong Liu-Seifert

Kristine Healey

Bruce J. Kinon

Saeed Ahmed

Ilya A. Lipkovich

Mauricio F. Tohen

Vicki Hoffmann

Dong Ding

Ellen Frank

Lizheng Shi

Janey Shin

Diego Novick

Paul Berg

Haya Ascher-Svanum

Josep Maria Haro

Isabelle Gasquet

Spyridon Tziveleskis

Fabio Blandini

Marie Therese Armentero

Roberto Fancellu

Giuseppe Nappi

David White

Mark Jensen

Barry Arnason

Samuel Frank

Karl Kieburtz

Robert Holloway

Renee Wilson

Carol Zimmerman

Scott Kim

Jordan J. Elm

Barbara C. Tilley

Yuko Y. Palesch

Paulo Guimaraes

Christopher Goetz

Bernard Ravina

Karl Keiburtz

Steven M. Leventer

Karen Raudibaugh

John C. Keogh

Robert F. Kucharik

Deirdre O’Hara

机构：

[1] Virginia Polytechnic Institute and State University,Department of Psychiatry

[2] Lilly Research Laboratories,Laboratory of Functional Neurochemistry

[3] University of Pittsburgh,Department of Neurology and Otorhinolaryngology

[4] Neurological Institute “C. Mondino,Department of Neurology

[5] ”,Department of Neurology

[6] University of Insubria,Psychiatry and Bioethics Program

[7] University of Rome “La Sapienza,Center for the Study of Neurodegenerative Diseases, Department of Neurology

[8] ”,Brigham and Women’s Hospital

[9] The University of Chicago,Maryland Psychiatric Research Center

[10] University of Rochester,Center for Neural Recovery and Rehabilitation Research

[11] University of Michigan,Department of Neurosurgery

[12] Baylor College of Medicine,Department of Neurology

[13] NeuroBiotec Berlin,Experimental Therapeutics Branch

[14] LKA Schwerin Schlaflabor,Department of Psychology

[15] Josefskrankenhaus Ruhr-Universität Bochum,Experimental Therapeutics Branch

[16] National Institute on Drug Abuse,undefined

[17] University of Virginia,undefined

[18] Pepgen Corporation,undefined

[19] Harvard Medical School,undefined

[20] Huntington Medical Research Institute,undefined

[21] University of Maryland School of Medicine,undefined

[22] Helen Hayes Hospital and Columbia University,undefined

[23] Columbia University School of Medicine,undefined

[24] University of Virginia,undefined

[25] National Institutes of Health/National Institutes of Neurological Disorders and Stroke Experimental Therapeutics Branch,undefined

[26] Titan Pharmaceuticals,undefined

[27] Inc.,undefined

[28] National Institutes of Health,undefined

[29] Central Michigan University,undefined

[30] National Institute of Neurological Disorders and Stroke,undefined

[31] Blanchette Rockefeller Neurosciences Institute,undefined

[32] University of Texas Medical Branch,undefined

[33] National Institute of Mental Health,undefined

来源：

NeuroRX | 2004年 / 1卷 / 4期

关键词：

Parkinson; 6-OHDA; tamoxifen; striatum;

D O I：

10.1602/neurorx.1.4.506

中图分类号：

学科分类号：

摘要：

引用

页码：506 / 514

页数：8

共 20 条

[1]

Jankovic J(1997)Long-term effects of tetrabenazine in hyperkinetic movement disorders Neurology 48 358-362

[2]

Beach J(2002)Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson’s disease Brain 125 2058-2066

[3]

Stocchi F(1992)Continuous lisuride effects on central dopaminergic mechanisms in Parkinson’s disease Ann Neurol 32 776-781

[4]

Ruggieri S(2003)Prognosis in amyotrophic lateral sclerosis: a population-based study Neurology 60 813-819

[5]

Vacca L(2002)Inhibition by R(+) or S(−) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH-SY5Y neuroblastoma J Neurosci Res 67 494-500

[6]

Olanow CW(2003)undefined Amyotroph Lateral Scler Other Motor Neuron Disord 11 1-6

[7]

Baronti F(undefined)undefined undefined undefined undefined-undefined

[8]

Mouradian MM(undefined)undefined undefined undefined undefined-undefined

[9]

Davis TL(undefined)undefined undefined undefined undefined-undefined

[10]

Giuffra M(undefined)undefined undefined undefined undefined-undefined

← 1 2 →